Literature DB >> 12902336

Enzymatic E-colicins bind to their target receptor BtuB by presentation of a small binding epitope on a coiled-coil scaffold.

Arun K Mohanty1, Christopher M Bishop, Thomas C Bishop, William C Wimley, Michael C Wiener.   

Abstract

Toxins and viruses often initiate their attacks by binding to specific proteins on the surfaces of target cells. Bacterial toxins (e.g. bacteriocins) and viruses (bacteriophages) targeting Gram-negative bacteria typically bind to outer membrane proteins. Bacterial E-colicins target Escherichia coli by binding to the outer membrane cobalamin transporter BtuB. Colicins are tripartite molecules possessing receptor-binding, translocation, and toxin domains connected by long coiled-coil alpha-helices. Surprisingly, the crystal structure of colicin E3 does not possess a recognizable globular fold in its receptor-binding domain. We hypothesized that the binding epitope of enzymatic E-colicins is a short loop connecting the two alpha-helices that comprise the coiled-coil region and that this flanking coiled-coil region serves to present the loop in a binding-capable conformation. To test this hypothesis, we designed and synthesized a 34-residue peptide (E-peptide-1) corresponding to residues Ala366-Arg399 of the helix-loop-helix region of colicin E3. Cysteines placed near the ends of the peptide (I372C and A393C) enabled crosslinking for reduction of conformational entropy and formation of a peptide structure that would present the loop epitope. A fluorescent analog was also made for characterization of binding by measurement of fluorescence polarization. Our analysis shows the following. (i). E-peptide-1 is predominantly random coil in aqueous solution, but disulfide bond formation increases its alpha-helical content in both aqueous buffer and solvents that promote helix formation. (ii). Fluorescein-labeled E-peptide-1 binds to purified BtuB in a calcium-dependent manner with a Kd of 43.6 +/- 4.9 nm or 2370 +/- 670 nm in the presence or absence of calcium, respectively. (iii). In the presence of calcium, cyanocobalamin (CN-Cbl) displaces E-peptide-1 with a nanomolar inhibition constant (Ki = 78.9 +/- 5.6 nm). We conclude that the BtuB binding sites for cobalamins and enzymatic E-colicins are overlapping but inequivalent and that the distal loop and (possibly) the short alpha-helical flanking regions are sufficient for high affinity binding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12902336     DOI: 10.1074/jbc.M308227200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Crystallization and preliminary X-ray crystallographic analysis of the Escherichia coli outer membrane cobalamin transporter BtuB in complex with the carboxy-terminal domain of TonB.

Authors:  David D Shultis; Michael D Purdy; Christian N Banchs; Michael C Wiener
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-06-10

2.  Cell entry mechanism of enzymatic bacterial colicins: porin recruitment and the thermodynamics of receptor binding.

Authors:  Nicholas G Housden; Steven R Loftus; Geoffrey R Moore; Richard James; Colin Kleanthous
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-15       Impact factor: 11.205

Review 3.  Structural and functional insights into colicin: a new paradigm in drug discovery.

Authors:  Ankita Pal; Papri Nath; Fatema Calcuttawala; Riya Kar; Debraj Hazra; Rajat Pal
Journal:  Arch Microbiol       Date:  2021-12-20       Impact factor: 2.552

4.  Polar residues in transmembrane helices can decrease electrophoretic mobility in polyacrylamide gels without causing helix dimerization.

Authors:  William F Walkenhorst; Mikhail Merzlyakov; Kalina Hristova; William C Wimley
Journal:  Biochim Biophys Acta       Date:  2009-03-02

5.  Flexibility in the receptor-binding domain of the enzymatic colicin E9 is required for toxicity against Escherichia coli cells.

Authors:  Christopher N Penfold; Bryan Healy; Nicholas G Housden; Ruth Boetzel; Mireille Vankemmelbeke; Geoffrey R Moore; Colin Kleanthous; Richard James
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

6.  Investigating early events in receptor binding and translocation of colicin E9 using synchronized cell killing and proteolytic cleavage.

Authors:  Ying Zhang; Mireille N Vankemmelbeke; Lisa E Holland; David C Walker; Richard James; Christopher N Penfold
Journal:  J Bacteriol       Date:  2008-04-11       Impact factor: 3.490

7.  Structure of colicin I receptor bound to the R-domain of colicin Ia: implications for protein import.

Authors:  Susan K Buchanan; Petra Lukacik; Sylvestre Grizot; Rodolfo Ghirlando; Maruf M U Ali; Travis J Barnard; Karen S Jakes; Paul K Kienker; Lothar Esser
Journal:  EMBO J       Date:  2007-04-26       Impact factor: 11.598

Review 8.  Colicin biology.

Authors:  Eric Cascales; Susan K Buchanan; Denis Duché; Colin Kleanthous; Roland Lloubès; Kathleen Postle; Margaret Riley; Stephen Slatin; Danièle Cavard
Journal:  Microbiol Mol Biol Rev       Date:  2007-03       Impact factor: 11.056

9.  Segmentally variable genes: a new perspective on adaptation.

Authors:  Yu Zheng; Richard J Roberts; Simon Kasif
Journal:  PLoS Biol       Date:  2004-04-13       Impact factor: 8.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.